Trial Profile
A Retrospective study of intravitreal Bevacizumab treatment in patients with macular edema secondary to branch retinal vein occlusion and central retinal vein occlusion (BERVOLT study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms BERVOLT
- 06 Apr 2017 New trial record